These results also support our hypothesis that miR-150 is downregulated by HDAC activation and that the inhibition of migration by miR-150 occurred independently of the p53 status in CTCL. This evidence concerns the gene HDAC9 and primary cutaneous T-cell non-Hodgkin lymphoma.